Fundraising Fox
/Companies
Sign in

novamind

Toronto · Founded 2020 · Canada (Federal Level) corporation · 168 employees on LinkedIn · 1 known investors

Find your way into novamind

Sign up to see every warm intro you have to novamind

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the novamind team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Numinus provides psychedelic-assisted therapy and mental health treatment, focusing on preparation, guided experiences, and post-session integration for individuals. It positions psychedelics as medicines requiring careful clinical support rather than standalone treatments.

BiotechDigital HealthMental HealthWellness & Fitness

Founders & leadership

novamind was founded in 2020 by Payton Nyquvest.

PNPayton Nyquvest
Payton NyquvestFounder
JP
JING PENGNamed on SEC filing
Y(
YISROEL (SRULI) WEINREBNamed on SEC filing
JK
JESSE KAPLANNamed on SEC filing
PGPRAKASH GOWD
PRAKASH GOWDChief Operating Officer & Head of Corporate Development2020–2022Interim President and CEO at Toronto Innovation Acceleration Partners
C(
CHARLES (CHUCK) RIFICINamed on SEC filing
SA
SENECA ANDERSONNamed on SEC filing
PT
PAUL THIELKINGNamed on SEC filing
PB
PIERRE BOU-MANSOURNamed on SEC filing
TW
TRACY WONGNamed on SEC filing
RR
REID ROBISONNamed on SEC filing
YC
YARON CONFORTINamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$8.8M disclosed across 3 rounds · 2020–2022

▶$4.7MraisedApr 2022 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jesse KaplanDirector
  • Dr. Reid RobisonExecutive Officer, Director
  • Paul ThielkingExecutive Officer
  • Nolan LadouceurExecutive Officer
  • Seneca AndersonExecutive Officer
  • Yaron ConfortiExecutive Officer, Director
  • Charles RificiDirector
  • Jing PengExecutive Officer
  • Samantha DeLenardoExecutive Officer
  • Prakash GowdExecutive Officer
  • Yisroel WeinrebDirector
Offering amount
$4.7M
Amount sold
$4.7M
First sale
Dec 2020
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.9MraisedFeb 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pierre Bou-MansourExecutive Officer
  • Charles RificiDirector
  • Yaron ConfortiExecutive Officer, Director
  • Nolan LadouceurExecutive Officer
  • Samantha DeLenardoExecutive Officer
  • Dr. Reid RobisonExecutive Officer, Director
  • Seneca AndersonExecutive Officer
  • Jing PengExecutive Officer
  • Paul ThielkingExecutive Officer
  • Prakash GowdExecutive Officer
  • Yisroel WeinrebDirector
  • Jesse KaplanDirector
Amount sold
$3.9M
Sales commissions
$314.6K
Placement agents
H.C. Wainwright & Co.
First sale
Jan 2022
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$164.5KraisedFeb 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JING PENGExecutive Officer
  • YISROEL (SRULI) WEINREBDirector
  • JESSE KAPLANDirector
  • PRAKASH GOWDExecutive Officer
  • CHARLES (CHUCK) RIFICIDirector
  • SENECA ANDERSONExecutive Officer
  • PAUL THIELKINGExecutive Officer
  • PIERRE BOU-MANSOURExecutive Officer
  • TRACY WONGExecutive Officer
  • REID ROBISONExecutive Officer, Director
  • YARON CONFORTIExecutive Officer, Director
  • NOLAN LADOUCEURExecutive Officer
Offering amount
$164.5K
Amount sold
$164.5K
First sale
Jan 2022
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does novamind do?
Numinus provides psychedelic-assisted therapy and mental health treatment, focusing on preparation, guided experiences, and post-session integration for individuals. It positions psychedelics as medicines requiring careful clinical support rather than standalone treatments.
Who founded novamind?
novamind was founded by Payton Nyquvest in 2020.
Who are novamind's investors?
novamind's investors include Clanton Capital.
How much funding has novamind raised?
novamind has disclosed $8.8M raised across 3 rounds.
Where is novamind headquartered?
novamind is headquartered in Toronto.